These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16722659)

  • 21. Effects of protein tyrosine kinase inhibitors on voltage-operated calcium channel currents in vascular smooth muscle cells and pp60(c-src) kinase activity.
    Wijetunge S; Lymn JS; Hughes AD
    Br J Pharmacol; 2000 Apr; 129(7):1347-54. PubMed ID: 10742290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linear and cyclic peptides as substrates for Lyn tyrosine kinase.
    Ruzza P; Donella-Deana A; Calderan A; Zanotti G; Cesaro L; Pinna LA; Borin G
    J Pept Sci; 1998 Feb; 4(1):33-45. PubMed ID: 9523754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and structure-activity relationships of 7-substituted 3-(2, 6-dichlorophenyl)-1,6-naphthyridin-2(1H)-ones as selective inhibitors of pp60(c-src).
    Thompson AM; Rewcastle GW; Boushelle SL; Hartl BG; Kraker AJ; Lu GH; Batley BL; Panek RL; Showalter HD; Denny WA
    J Med Chem; 2000 Aug; 43(16):3134-47. PubMed ID: 10956222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of src family kinases by a combinatorial action of 5'-AMP and small heat shock proteins, identified from the adult heart.
    Kasi VS; Kuppuswamy D
    Mol Cell Biol; 1999 Oct; 19(10):6858-71. PubMed ID: 10490624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATP-phosphopeptide conjugates as inhibitors of Src tyrosine kinases.
    Nam NH; Lee S; Ye G; Sun G; Parang K
    Bioorg Med Chem; 2004 Nov; 12(22):5753-66. PubMed ID: 15498652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. pp60(c-src) and related tyrosine kinases: a role in the assembly and reorganization of matrix adhesions.
    Volberg T; Romer L; Zamir E; Geiger B
    J Cell Sci; 2001 Jun; 114(Pt 12):2279-89. PubMed ID: 11493667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptide inhibitors of src SH3-SH2-phosphoprotein interactions.
    Gilmer T; Rodriguez M; Jordan S; Crosby R; Alligood K; Green M; Kimery M; Wagner C; Kinder D; Charifson P
    J Biol Chem; 1994 Dec; 269(50):31711-9. PubMed ID: 7527393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformation-selective inhibitors reveal differences in the activation and phosphate-binding loops of the tyrosine kinases Abl and Src.
    Hari SB; Perera BG; Ranjitkar P; Seeliger MA; Maly DJ
    ACS Chem Biol; 2013 Dec; 8(12):2734-43. PubMed ID: 24106839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic peptides incorporating 4-carboxyphenylalanine and phosphotyrosine are potent inhibitors of pp60(c-)(src).
    Wang W; Ramdas L; Sun G; Ke S; Obeyesekere NU; Budde RJ; McMurray JS
    Biochemistry; 2000 May; 39(17):5221-8. PubMed ID: 10819990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The design, synthesis and activity of non-ATP competitive inhibitors of pp60(c-src) tyrosine kinase. Part 2: hydroxyindole derivatives.
    Milkiewicz KL; Marsilje TH; Woodworth RP; Bifulco N; Hangauer MJ; Hangauer DG
    Bioorg Med Chem Lett; 2000 Mar; 10(5):483-6. PubMed ID: 10743953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An exploration of the effects of constraints on the phosphorylation of synthetic protein tyrosine kinase peptide substrates.
    Ruzza P; Donella-Deana A; Calderan A; Filippi B; Cesaro L; Pinna LA; Borin G
    J Pept Sci; 1996; 2(5):325-38. PubMed ID: 9230460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of indole esters as inhibitors of p60(c-Src) receptor tyrosine kinase and investigation of the inhibition using receptor docking studies.
    Olgen S; Akaho E; Nebioglu D
    J Enzyme Inhib Med Chem; 2003 Dec; 18(6):485-90. PubMed ID: 15008512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as potent Src kinase inhibitors.
    Berger DM; Dutia M; Birnberg G; Powell D; Boschelli DH; Wang YD; Ravi M; Yaczko D; Golas J; Lucas J; Boschelli F
    J Med Chem; 2005 Sep; 48(19):5909-20. PubMed ID: 16161995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrophobic D-amino acids in the design of peptide ligands for the pp60src SH2 domain.
    Plummer MS; Lunney EA; Para KS; Prasad JV; Shahripour A; Singh J; Stankovic CJ; Humblet C; Fergus JH; Marks JS; Sawyer TK
    Drug Des Discov; 1996 Apr; 13(3-4):75-81. PubMed ID: 8874045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The design, synthesis and activity of pentapeptide pp60c-src inhibitors containing L-phosphotyrosine mimics.
    Lai JH; Marsilje TH; Choi S; Nair SA; Hangauer DG
    J Pept Res; 1998 Apr; 51(4):271-81. PubMed ID: 9560002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for the involvement of a Src-related tyrosine kinase in Xenopus egg activation.
    Sato K; Iwao Y; Fujimura T; Tamaki I; Ogawa K; Iwasaki T; Tokmakov AA; Hatano O; Fukami Y
    Dev Biol; 1999 May; 209(2):308-20. PubMed ID: 10328923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.
    Waltenberger J; Uecker A; Kroll J; Frank H; Mayr U; Bjorge JD; Fujita D; Gazit A; Hombach V; Levitzki A; Böhmer FD
    Circ Res; 1999 Jul; 85(1):12-22. PubMed ID: 10400906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
    Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
    J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and pp60c-Src tyrosine kinase inhibitory activities of novel indole-3-imine and amine derivatives substituted at N1 and C5.
    Kiliç Z; Isgör YG; Olgen S
    Arch Pharm (Weinheim); 2009 Jun; 342(6):333-43. PubMed ID: 19475593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Src-Abl tyrosine kinase chimeras: replacement of the adenine binding pocket of c-Abl with v-Src to swap nucleotide and inhibitor specificities.
    Liu Y; Witucki LA; Shah K; Bishop AC; Shokat KM
    Biochemistry; 2000 Nov; 39(47):14400-8. PubMed ID: 11087392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.